Vanguard Personalized Indexing Management’s Lyell Immunopharma LYEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,644
| Closed | -$17.7K | – | 1998 |
|
|
2025
Q1 | $17.7K | Buy |
1,644
+525
| +47% | +$5.65K | ﹤0.01% | 1786 |
|
|
2024
Q4 | $14.3K | Buy |
+1,119
| New | +$14.3K | ﹤0.01% | 1787 |
|
|
2024
Q3 | – | Sell |
-934
| Closed | -$27.1K | – | 1802 |
|
|
2024
Q2 | $27.1K | Buy |
934
+115
| +14% | +$3.34K | ﹤0.01% | 1628 |
|
|
2024
Q1 | $36.5K | Buy |
819
+23
| +3% | +$1.03K | ﹤0.01% | 1581 |
|
|
2023
Q4 | $30.9K | Buy |
+796
| New | +$30.9K | ﹤0.01% | 1533 |
|